Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to recipients' variants.

T KhawajaM KajovaI LevonenJ P PietiläH VälimaaJ PaajanenS H PakkanenA PatjasR MontonenS MiettinenJ VirtanenT SmuraT SironenR FagerlundH UgurluR Iheozor-EjioforK SakselaT VahlbergA RankiA VierikkoJ IhalainenO VapalahtiA Kantele

Published in: Infectious diseases (London, England) (2024)

ClinTrials.gov identifier: NCT0473040.

Keyphrases

double blind
coronavirus disease
sars cov
clinical trial
study protocol
placebo controlled
copy number
dna repair
open label
dna damage
kidney transplantation
respiratory syndrome coronavirus
gene expression
oxidative stress
dna methylation